English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 22, 2026

Experimental neurointerventional technique shows promise for severe back pain
+ Pharmaceuticals
Patient Daily | Jul 22, 2026

Repligen announces $1.5 billion acquisition of BioLife Solutions for cell therapy products
+ Pharmaceuticals
Patient Daily | Jul 22, 2026

Survey shows many Americans uncertain about CDC pregnancy vaccine recommendations
+ Pharmaceuticals
Patient Daily | Jul 22, 2026

Study links higher red meat intake to increased pancreatic cancer risk
+ Pharmaceuticals
Patient Daily | Jul 22, 2026

Transitioning from large pharmaceutical firms to specialty pharma shifts focus to patient proximity
+ Pharmaceuticals
Patient Daily | Jul 21, 2026

AHA statement links moderate coffee intake to lower cardiovascular risk in new review
+ Pharmaceuticals
Patient Daily | Jul 21, 2026

Federal court orders EPA to implement national soot pollution standard by February 2027
+ Pharmaceuticals
Patient Daily | Jul 21, 2026

FDA’s 505(b)(2) pathway offers a strategic route for drug development and innovation

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes